Key result
Higher preprocedural monocyte distribution width is linked to ~17% higher in-stent restenosis odds per fL.
Why the study?
In-stent restenosis remains an important complication after percutaneous coronary intervention with drug-eluting stents, and the independent association between preprocedural monocyte distribution width and in-stent restenosis needed investigation.
Is higher preprocedural monocyte distribution width (MDW) independently associated with an increased risk of in-stent restenosis within 6–14 months in patients with coronary artery disease undergoing drug-eluting stent implantation?
Cohort (n=982)
Single-blind
No
Is higher preprocedural monocyte distribution width (MDW) independently associated with an increased risk of in-stent restenosis within 6–14 months in patients with coronary artery disease undergoing drug-eluting stent implantation?
Answers are grounded in this paper and cite their sources.
Preprocedural monocyte distribution width (MDW) is independently and linearly associated with the risk of in-stent restenosis within 6–14 months after drug-eluting stent implantation, suggesting its potential utility as a routine hematologic biomarker for post-PCI risk stratification.
Objective Drug-eluting stents (DES) have substantially improved outcomes in patients with coronary artery disease, yet in-stent restenosis (ISR) remains an important complication after percutaneous coronary intervention (PCI). We investigated the association between preprocedural monocyte distribution width (MDW) and ISR after DES implantation and examined whether this association persisted after adjustment for established clinical and procedural risk factors. Methods This single-center retrospective cohort study included consecutive patients with coronary artery disease who underwent successful DES implantation between April 2022 and March 2025. Of 1,035 eligible patients, 982 had definitive ISR assessment by coronary angiography or coronary computed tomography angiography within 6–14 months after PCI and were included in the primary analysis. Multivariable logistic regression was used to assess the association between MDW and ISR, adjusting for age, diabetes mellitus, lesion complexity, total stent length, average stent diameter, and low-density lipoprotein cholesterol (LDL-C). Restricted cubic spline analysis was used to examine the shape of the association, and robustness was evaluated in the primary coronary angiography follow-up cohort and in additional sensitivity analyses. Results Among the 982 patients in the primary analysis, 89 ISR events were identified (9.1%). Preprocedural MDW was higher in patients with ISR than in those without ISR [23.1 (20.2–26.5) fL vs. 20.9 (18.7–23.6) fL, P < 0.001]. Restricted cubic spline analysis showed a significant overall association between MDW and ISR, with no evidence of nonlinearity (P for overall association < 0.001; P for nonlinearity=0.417). After multivariable adjustment, each 1-fL increase in MDW was associated with higher odds of ISR (OR = 1.17, 95% CI: 1.07–1.28; P < 0.001). Similar results were observed among the 742 patients for whom coronary angiography was the primary follow-up imaging modality (OR = 1.15, 95% CI: 1.05–1.27; P = 0.003). Conclusion Higher preprocedural MDW was associated with ISR after DES implantation independently of the prespecified clinical and procedural factors . The association persisted in sensitivity analyses, including additional adjustment for absolute monocyte count or hs-CRP . MDW may reflect a monocyte-related inflammatory phenotype linked to ISR susceptibility, but its incremental predictive value, optimal threshold, and clinical utility remain to be established in independent multicenter prospective studies .
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) conducted a cohort in Coronary artery disease treated with drug-eluting stent implantation (n=982). Preprocedural monocyte distribution width (MDW) per 1-fL increase vs. Lower preprocedural MDW (continuous variable) was evaluated on In-stent restenosis (ISR) defined as ≥50% diameter stenosis within the stented segment or within 5 mm of either stent edge at 6–14 months (OR 1.17, 95% CI 1.07-1.28, p=<0.001). Each 1-fL increase in preprocedural monocyte distribution width was independently associated with higher odds of in-stent restenosis after DES implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: